Browsing Tag
Galvanize Therapeutics
2 posts
From hearts to tumors: How pulsed electric field technology is making the leap into oncology
Galvanize’s PROPEL Registry highlights how pulsed electric field ablation, first used in arrhythmia care, is now emerging in oncology. Learn why adoption matters.
Galvanize Therapeutics enrolls first patient in PROPEL Registry for Aliya pulsed electric field ablation in soft tissue lesions
Galvanize enrolls first patient in PROPEL Registry for Aliya pulsed electric field ablation in soft tissue tumors. Find out what this means for oncology.